Table 4 Treatment and healthcare utilization in patients who experienced asthma exacerbation
Total | No obesity | Obesity | P | |
|---|---|---|---|---|
n = 379* | n = 216 | n = 163 | ||
Corticosteroid use | 341 (90.0) | 191 (88.4) | 150 (92.0) | 0.048 |
Duration of corticosteroid use, days | 11.5 ± 11.5 | 10.4 ± 10.5 | 12.8 ± 12.6 | 0.066 |
Admission rate | 366 (96.6) | 208 (96.3) | 158 (96.9) | 0.736 |
ICU admission rate | 35 (9.2) | 23 (10.6) | 12 (7.4) | 0.274 |
Duration of hospitalization, days | 9.7 ± 7.9 | 9.7 ± 8.3 | 9.7 ± 7.4 | 0.940 |
Duration of exacerbation, days | 11.0 ± 8.8 | 10.4 ± 8.4 | 11.7 ± 9.2 | 0.159 |
Antibiotics | 337 (88.9) | 190 (88.0) | 147 (90.2) | 0.733 |
Beta-lactam | 227 (67.4) | 127 (66.8) | 100 (68.0) | |
Quinolone | 77 (22.8) | 40 (21.1) | 37 (25.2) | |
Macrolide | 20 (5.9) | 13 (6.8) | 7 (4.8) | |
Miscellaneous | 13 (3.9) | 10 (5.3) | 3 (2.0) |